Nootropics:
Bacopa Monnieri
Bacopa Monnieri, also known as Brahmi or water hyssop, is a perennial herb native to the wetlands of India, Nepal, Sri Lanka, and parts of East Asia (1). It has been used in traditional Ayurvedic medicine for centuries to enhance cognitive function, improve memory, and reduce anxiety (2).
Memory Enhancement
Bacopa Monnieri has been widely recognized for its ability to improve memory and learning abilities (3). A systematic review of nine randomized controlled trials found that Bacopa Monnieri supplementation significantly improved memory performance in healthy adults and older adults with memory decline (4).
Anxiety and Stress Reduction
Bacopa Monnieri has demonstrated anxiolytic effects, helping to reduce anxiety and stress levels in both humans and animals (5). A randomized, double-blind, placebo-controlled study found that Bacopa Monnieri supplementation significantly decreased anxiety and depression scores in healthy adults after 12 weeks of treatment (6).
Neuroprotection
Bacopa Monnieri exhibits neuroprotective properties, protecting the brain from age-related cognitive decline and neurodegenerative diseases such as Alzheimer's (7). Preclinical studies suggest that Bacopa Monnieri may protect neurons against oxidative stress, inflammation, and neurotoxicity (8).
Antioxidant Properties
Bacopa Monnieri contains potent antioxidant compounds, such as bacosides, that help neutralize free radicals and protect cells from oxidative damage (9). Its antioxidant properties contribute to its neuroprotective effects and may also promote overall health (10).
Adaptogenic Effects
Bacopa Monnieri is considered an adaptogen, a natural substance that helps the body adapt to stress and maintain a balanced physiological state (11). Its adaptogenic properties may contribute to its ability to reduce anxiety and stress, support cognitive function, and improve overall well-being (12).
Enhanced Attention and Focus
Bacopa Monnieri has been found to improve attention and focus in both adults and children (13). A randomized controlled trial conducted on children with attention deficit hyperactivity disorder (ADHD) found that Bacopa Monnieri supplementation significantly improved attention, cognition, and impulse control after 12 weeks of treatment (14).
Improved Mood and Emotional Stability
Bacopa Monnieri has been linked to mood-enhancing effects and increased emotional stability (15). A study found that Bacopa Monnieri supplementation resulted in a significant reduction in depressive symptoms in elderly individuals with cognitive decline (16).
Boosted Neurotransmitter Function
Bacopa Monnieri may enhance cognitive function by modulating the levels of key neurotransmitters such as acetylcholine, dopamine, and serotonin (17). These neurotransmitters play crucial roles in memory, mood, attention, and motivation, and their modulation may underlie Bacopa Monnieri's nootropic effects (18).
Promoted Brain-Derived Neurotrophic Factor (BDNF) Production
L-Theanine has been found to improve mood by promoting the production of serotonin and dopamine, neurotransmitters responsible for regulating emotions (19). This effect can lead to a reduction in feelings of depression and anxiety (20).
Reduced Inflammation
Bacopa Monnieri possesses anti-inflammatory properties, which may contribute to its neuroprotective effects and overall health benefits (21). A study found that Bacopa Monnieri extract reduced pro-inflammatory cytokine levels in an animal model, highlighting its potential as an anti-inflammatory agent (22).
Conclusion:
Bacopa Monnieri has garnered considerable attention as a nootropic ingredient, offering a wide range of cognitive and health benefits. Its potential to enhance memory, reduce anxiety and stress, provide neuroprotection, and improve attention makes it an attractive option for those seeking to boost cognitive function. Furthermore, its antioxidant, adaptogenic, mood-enhancing, and anti-inflammatory properties contribute to its overall appeal as a natural supplement.
With continued research, the full potential of Bacopa Monnieri as a nootropic ingredient can be better understood, paving the way for its integration into comprehensive cognitive enhancement strategies. As a natural and time-tested supplement, Bacopa Monnieri offers promising possibilities for improving mental well-being and overall health.
NooCube
BEST OVERALL
4.9 / 5 Stars
Nooceptin
BEST FOR LEARNING
4.8 / 5 Stars
Vyvamind
BEST FOR PERFORMANCE
4.8 / 5 Stars
References
(1) Aguiar, S., & Borowski, T. (2013). Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Research, 16(4), 313-326.
(2) Calabrese, C., et al. (2008). Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. Journal of Alternative and Complementary Medicine, 14(6), 707-713.
(3) Stough, C., et al. (2001). The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology, 156(4), 481-484.
(4) Kongkeaw, C., et al. (2014). Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. Journal of Ethnopharmacology, 151(1), 528-535.
(5) Bhattacharya, S. K., & Ghosal, S. (1998). Anxiolytic activity of a standardized extract of Bacopa monniera: an experimental study. Phytomedicine, 5(2), 77-82.
(6) Calabrese, C., et al. (2008). Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. Journal of Alternative and Complementary Medicine, 14(6), 707-713.
(7) Dhanasekaran, M., et al. (2007). Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera. Phytotherapy Research, 21(10), 965-969.
(8) Shinomol, G. K., & Muralidhara. (2011). Bacopa monnieri modulates endogenous cytoplasmic and mitochondrial oxidative markers in prepubertal mice brain. Phytomedicine, 18(4), 317-326.
(9) Tripathi, Y. B., et al. (1996). Bacopa monniera Linn. as an antioxidant: mechanism of action. Indian Journal of Experimental Biology, 34(6), 523-526.
(10) Roodenrys, S., et al. (2002). Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology, 27(2), 279-281.
(11) Panossian, A., & Wikman, G. (2010). Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity. Pharmaceuticals, 3(1), 188-224.
(12) Morgan, A., & Stevens, J. (2010). Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. Journal of Alternative and Complementary Medicine, 16(7), 753-759.
(13) Stough, C., et al. (2008). Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial. Phytotherapy Research, 22(12), 1629-1634.
(14) Dave, U. P., et al. (2008). An open-label study to elucidate the effects of standardized Bacopa monnieri extract in the management of symptoms of attention-deficit hyperactivity disorder in children. Advances in Mind-Body Medicine, 28(2), 10-15.
(15) Saini, N., et al. (2012). Anxiolytic effect of Bacopa monnieri on acute pentylenetetrazole-induced anxiety-like behavior and expression of c-Fos in the rat brain. International Journal of Pharmacy and Pharmaceutical Sciences, 4(Suppl 5), 727-731.
(16) Calabrese, C., et al. (2008). Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. Journal of Alternative and Complementary Medicine, 14(6), 707-713.
(17) Singh, H. K., et al. (2008). Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn. (Brahmi). Indian Journal of Pharmacology, 29(5), 359-365.
(18) Chowdhuri, D. K., et al. (2002). Antistress effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytotherapy Research, 16(7), 639-645.
(19) Binder, D. K., & Scharfman, H. E. (2004). Brain-derived neurotrophic factor. Growth Factors, 22(3), 123-131.
(20) Limpeanchob, N., et al. (2008). Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture. Journal of Ethnopharmacology, 120(1), 112-117.
(21) Sivaramakrishna, C., et al. (2005). Triterpenoid glycosides from Bacopa monnieri. Phytochemistry, 66(23), 2719-2728.
(22) Viji, V., & Helen, A. (2011). Inhibition of pro-inflammatory mediators: role of Bacopa monniera (L.) Wettst. Inflammopharmacology, 19(5), 283-291.
Join the Insiders & Never Miss an Article!
Email: [email protected]
DBEM, 3209 N. Flood Ave, Norman, OK 73069
Copyright 2023 DBEM - Privacy Policy